مواقع التدريسيينجامعة الكوفة
Ali Jabir Neima Duabil
Assistant Professor

Ali Jabir Neima Duabil

0Publications
0Lectures
0Interests

About

Mbchb from Baghdsd univrsity/college of medicine in 1993
Junior dctor for 2years till September 1995
5years training in general surgery and and granted fellow of Iraqi board in medical specialization in general surgery.
Asdistant prof.in general surgery in2011.
Consultant in general surgery in 2011

Research Interests

1

Publications

3
2020

Pattern and distribution of cancers in areas of Iraq exposed to Depleted Uranium

Authorsesraa aldujaily, Liwaa Al Kelabi View ORCID ProfileEsraa Aldujaily, Ali Duabil, Kussay M. Abbas Zwain, Hayder K. Fatlawi, View ORCID ProfileAli Al-Behadili, Emad Al saabery, Yasseen A. Alwaaely, Sijal Al Joboury, Omar Layth Qassid
JournalEuropean Journal of Molecular and clinical medicine
Abstract

European Journal of Molecular and clinical medicine

2019

Expression of Beta‑Human Chorionic Gonadotropin as a Prognostic Factor in Colorectal Carcinoma

AuthorsHameed Naeem Mosa, Esraa Abdulaal Aldujaily, Ali Jabir Duabil, Liwaa Hussein Alkelabi, Azhar Naji Alnajim, Faiza Aftan Al‑Raw
JournalMedical Journal of Babylon
Abstract

Colorectal carcinoma (CRC) is a common malignancy in Iraq and carries a high mortality rate. It has been shown that CRCs express high level of beta-human chorionic gonadotropin (β-HCG) as detected by immunohistochemistry.

2010

HER-2/neu overexpression in correlation to Vascular Endothelial Growth Factor, grade and stage of Non other wised specified Invasive ductal carcinoma

AuthorsEsraa A AL-Dujaily, , Liwaa H Al-Kelabi, Ali Jabir Neima Alkhafaji, Esraah SM Al-Harris
JournalAL-QADISIYAH MEDICAL JOURNAL
Abstract

الوصف This study aimed to assess the significance of human epidermal growth factor (HER-2/neu) protein overexpression and its possible correlation with vascular endothelial growth factor (VEGF), grade and stage in human non otherwise specified breast cancer. The present investigation was performed over a period starting from November 2008 to January 2009. Formalin fixed, paraffin-embedded blocks from 30 patients with breast cancer were included in this study. A group of 15 patients with benign breast lesions (fibroadenoma) was included as a comparative group and 15 normal breast tissue sections were included as control group. Labeled Streptavidin-Biotin Complex (LSAB) method was employed for immunohistochemical detection of HER-2/neu. Avidin-Biotin Complex (ABC) method was employed for immunohistochemical detection of VEGF. A total of 30 malignant cases were included. HER2/neu was considered as positive in (18 cases) 60% of non otherwise specified invasive ductal carcinoma and VEGF was considered as positive in (21cases) 70% with concomitant positivity of both markers in more than half (16 cases) 53.3% out of 30 malignant cases. No overexpression of both markers have been noticed in normal or benign (fibroadenoma) breast tissue sections with significant difference from that of malignant cases (P< 0.05). We did not find any significant difference between overexpression of both (HER-2/neu and VEGF) in relation to age, tumor size, tumor stage and positive or negative lymph node breast cancer cases (P> 0.05). However there was positive relation between HER-2/neu overexpression and the grade of tumor (P<

Lectures

3

SHOCK

GIT MODULE

GIT bleeding

GIT MODULE

spleen and pancreas

GIT block

View details